[{"NetIncomeLoss":448500000.0,"PropertyPlantAndEquipmentNet":3442200000.0,"DebtSecuritiesAvailableForSaleRealizedGain":100000.0,"ProceedsFromPaymentsForOtherFinancingActivities":-20500000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent":226300000.0,"DeferredIncomeTaxLiabilitiesNet":918900000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits":0.029,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":11214800000.0,"PaymentsToAcquireIntangibleAssets":0.0,"CashEquivalentsAtCarryingValue":1180200000.0,"AdditionalPaidInCapital":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment":400000.0,"EquitySecuritiesFvNiRealizedGainLoss":400000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":0.21,"IntangibleAssetsNetExcludingGoodwill":2385000000.0,"OtherAccruedLiabilitiesCurrent":760300000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential":-0.077,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":1742000000.0,"InterestExpense":56400000.0,"NonoperatingIncomeExpense":96400000.0,"AccountsPayableCurrent":375300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":429400000.0,"LiabilitiesCurrent":3347200000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill":0.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue":1308900000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent":0.0,"WeightedAverageNumberOfSharesOutstandingBasic":149700000.0,"RepaymentsOfDebt":170000000.0,"InventoryRawMaterialsNetOfReserves":328000000.0,"NetCashProvidedByUsedInOperatingActivities":1996300000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax":15900000.0,"ValuationAllowancesAndReservesBalance":1202300000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation":14200000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment":28100000.0,"Goodwill":5763900000.0,"PaymentsForProceedsFromDerivativeInstrumentFinancingActivities":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":1400000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent":2500000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":1880300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree":225000000.0,"IncomeLossFromEquityMethodInvestments":16100000.0,"DebtInstrumentFairValue":8140700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour":220000000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses":0.0,"EarningsPerShareDiluted":2.99,"DeferredTaxAssetsGross":875000000.0,"AssetImpairmentCharges":0.0,"IncreaseDecreaseInAccountsReceivable":-211500000.0,"RetainedEarningsAccumulatedDeficit":13900700000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax":-11000000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization":-0.008,"TaxesPayableCurrent":230900000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive":200000000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis":2223600000.0,"PaymentsToAcquirePropertyPlantAndEquipment":164500000.0,"PaymentsToMinorityShareholders":94800000.0,"StockholdersEquity":10751900000.0,"ConstructionPayableCurrentAndNoncurrent":72400000.0,"OtherLiabilitiesCurrent":2741000000.0,"OtherLiabilitiesNoncurrent":1356400000.0,"ProfitLoss":1025500000.0,"DeferredTaxAssetsLiabilitiesNet":500000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear":110000000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":0.013,"StockIssuedDuringPeriodValueTreasuryStockReissued":13700000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesEquity":91200000.0,"DeferredTaxAssetsValuationAllowance":375000000.0,"AllocatedShareBasedCompensationExpense":-55800000.0,"EmployeeRelatedLiabilitiesCurrent":242500000.0,"LiabilitiesAndStockholdersEquity":24470400000.0,"DeferredIncomeTaxExpenseBenefit":-622800000.0,"PreferredStockValue":0.0,"InvestmentIncomeInterest":2700000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax":-400000.0,"InventoryNet":1254800000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable":171500000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent":1308800000.0,"PaymentsForRepurchaseOfCommonStock":1050000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments":582100000.0,"OperatingIncomeLoss":485700000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost":870900000.0,"NotesPayable":7269200000.0,"CommonStockParOrStatedValuePerShare":0.0005,"AccruedIncomeTaxesNoncurrent":652700000.0,"DeferredIncomeTaxAssetsNet":1849900000.0,"PreferredStockParOrStatedValuePerShare":0.001,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount":1700000.0,"OperatingLeaseRightOfUseAsset":402500000.0,"ShareBasedCompensation":124100000.0,"StockholdersEquityOther":0.0,"OtherComprehensiveIncomeLossNetOfTax":2400000.0,"Assets":24470400000.0,"AvailableForSaleSecuritiesDebtSecurities":2223900000.0,"InventoryWorkInProcessNetOfReserves":723000000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities":633500000.0,"GainLossOnDerivativeInstrumentsNetPretax":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax":-500000.0,"TreasuryStockValue":2977100000.0,"GoodwillImpairedAccumulatedImpairmentLoss":0.0,"ResearchAndDevelopmentInProcess":18000000.0,"AvailableForSaleSecurities":2223900000.0,"StockIssuedDuringPeriodValueStockOptionsExercised":-800000.0,"AllocatedShareBasedCompensationExpenseNetOfTax":59400000.0,"CostOfGoodsAndServicesSold":459700000.0,"ProceedsFromIssuanceOfLongTermDebt":0.0,"SellingGeneralAndAdministrativeExpense":637300000.0,"IncreaseDecreaseInEquitySecuritiesFvNi":-283600000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt":1626900000.0,"OtherNoncashIncomeExpense":-112400000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax":49000000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease":-2300000.0,"LongTermDebt":7269200000.0,"AssetsCurrent":7183700000.0,"PaymentsForProceedsFromOtherInvestingActivities":-2000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":1100000.0,"Depreciation":54700000.0,"NetCashProvidedByUsedInInvestingActivities":-217400000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense":10900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax":-171800000.0,"InventoryFinishedGoodsNetOfReserves":203800000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest":576900000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax":78200000.0,"CommitmentsAndContingencies":null,"RepaymentsOfLongTermDebt":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo":215000000.0,"AccruedRoyaltiesCurrent":240300000.0,"EquitySecuritiesFvNiGainLoss":154300000.0,"NetIncomeLossAttributableToNoncontrollingInterest":577000000.0,"EffectiveIncomeTaxRateReconciliationOtherAdjustments":0.004,"IncreaseDecreaseInOtherOperatingCapitalNet":97300000.0,"Liabilities":13255600000.0,"DebtSecuritiesAvailableForSaleRealizedLoss":500000.0,"OperatingLeaseLiabilityNoncurrent":363900000.0,"OtherAssetsNoncurrent":2528100000.0,"ComprehensiveIncomeNetOfTax":451000000.0,"GoodwillOtherIncreaseDecrease":1800000.0,"IncreaseDecreaseInInventories":193800000.0,"OtherAssetsCurrent":767900000.0,"CostsAndExpenses":2289300000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill":585900000.0,"RealizedInvestmentGainsLosses":153900000.0,"NetCashProvidedByUsedInFinancingActivities":-1349500000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost":585100000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost":1308800000.0,"EffectiveIncomeTaxRateContinuingOperations":-0.703,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings":-300000.0,"ForeignCurrencyTransactionGainLossBeforeTax":-800000.0,"IntangibleAssetsGrossExcludingGoodwill":7637700000.0,"PaymentsToAcquireInProcessResearchAndDevelopment":0.0,"DepreciationDepletionAndAmortization":219800000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue":870500000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent":915100000.0,"Revenues":2775000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents":-18600000.0,"CommonStockValue":100000.0,"NumberOfReportableSegments":1.0,"IncomeTaxExpenseBenefit":-409100000.0,"AccountsReceivableNetCurrent":1688000000.0,"OtherNonoperatingIncomeExpense":-3000000.0,"IncreaseDecreaseInAccruedLiabilities":-188400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding":150100000.0,"PaymentsOfFinancingCosts":24400000.0,"EquitySecuritiesFvNiUnrealizedGainLoss":153900000.0,"MinorityInterest":462900000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths":215000000.0,"EarningsPerShareBasic":3.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization":5252700000.0,"IncreaseDecreaseInDueFromRelatedParties":8700000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments":4800000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest":1027900000.0,"AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears":48800000.0,"AmortizationAndImpairmentOfAcquiredIntangibleAssets":604100000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost":44200000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue":44200000.0,"Collaborationexpensesaccrual":383400000.0,"Collaborationprofitlosssharing":-15200000.0,"CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear":1960000000.0,"DuefromantiCD20therapeuticprograms":422200000.0,"EffectiveTaxRateReconciliationGILTItax":0.015,"EffectiveTaxRateReconciliationNuerImmuneTaxImpacts":-0.831,"IncomeLossFromEquityMethodInvestmentsNetOfTax":34300000.0,"InterestInSubsidiary":1.0,"Inventorynetcurrentandnoncurrent":1254800000.0,"InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities":15200000.0,"NoncontrollingInterestCapitalContribution":5100000.0,"NoncontrollingInterestIncreaseDecreaseOther":-100000000.0,"NumberOfWholesalers":2.0,"PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear":1182400000.0,"PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear":802500000.0,"ShareBasedCompensationExpenseIncludedInCostsAndExpenses":57700000.0,"TechnologicalAndRegulatorySuccessProbability":0.217,"UnrealizedGainLossesOnForeignCurrencyDerivativesNetBeforeTax":-53700000.0,"UnrealizedGrossGainsOnForeignCurrencyDerivativesNetBeforeTax":13300000.0,"UnrealizedGrossLossesOnForeignCurrencyDerivativesNetBeforeTax":67000000.0,"ddate":20210630,"qtrs":1,"uom":"USD","footnote":null,"form":"10-Q","period":20210630.0,"fy":2021.0,"fp":"Q2","Symbol":"BIIB","GICS Sector":"Health Care","GICS Sub-Industry":"Biotechnology"}]